Tolerance Bio, Inc.
PrivateLast Round
Early Stage
VC
Jun 18, 2026
Total Funding Raised
$20.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Tolerance Bio, Inc. is a biopharmaceutical company developing therapies focused on manipulating immune tolerance via the thymus to address various immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tolerance Bio, Inc. Comparables
Compare Tolerance Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thymmune Therapeutics | 90% | |
| TECregen | 76% | |
| Sumitomo Pharma Co., Ltd. | 73% | |
Tolerance Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jun 18, 2026 | ||||
| Seed | Dec 19, 2024 |
Key People
Founding team and executive leadership
Tolerance Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pacific 8 Ventures | Seed |
| Benjamin Franklin Technology Partners | Seed |
| Sessa Capital | Seed |
| BioAdvance Capital | Seed |
| Caixa Capital Risc | Seed |
| Columbus Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
$15.1M raised in an early stage VC round.
Tolerance Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tolerance Bio, Inc.'s valuation, stock price, and market status.